Antidiabetic drugs and the risk of cancer: beneficial, neutral, or detrimental?
The prevalence of diabetes mellitus is rapidly rising, especially in low- and middle-income countries. Also, early-onset diabetes is on the rise, and millions of individuals have to be on antidiabetic medications for a prolonged period. Therefore, more people are getting exposed to the adverse effec...
Saved in:
| Main Authors: | Azeez Taoreed Adegoke, Folorunso Sharif Adeniyi, Eguzozie Chinedu, Adegboyega Adeleke Adedapo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2021-08-01
|
| Series: | Forum of Clinical Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/fco-2021-0014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antidiabetic agents as potential cytotoxic candidates for cancer therapy
by: Alnaser Raniah I., et al.
Published: (2025-06-01) -
Antidiabetic potential of Gynura procumbens (Lour.) Merr.: a review of in vitro and in vivo studies
by: Nurul Hafizah Mohd Nor, et al.
Published: (2025-08-01) -
Exploring the antidiabetic potential of Bridelia tomentosa blume against streptozotocin (STZ)-induced diabetic Sprague-Dawley rats
by: Kakoli Rani Mondal, et al.
Published: (2025-08-01) -
Antidiabetic assessment of mango and soursop leaves bioactive phytochemical formulation on streptozotocin-induced rat model
by: Churchill Chisom Ogbonna, et al.
Published: (2025-08-01) -
Comparative effectiveness of combining antidiabetic medications to treat renal impairment in patients with type 2 diabetes mellitus
by: Qiu Mo, et al.
Published: (2025-07-01)